These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
400 related items for PubMed ID: 16125836
1. The structure of human apolipoprotein E2, E3 and E4 in solution. 2. Multidomain organization correlates with the stability of apoE structure. Clément-Collin V, Barbier A, Dergunov AD, Visvikis A, Siest G, Desmadril M, Takahashi M, Aggerbeck LP. Biophys Chem; 2006 Jan 20; 119(2):170-85. PubMed ID: 16125836 [Abstract] [Full Text] [Related]
2. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease. Aleshkov S, Abraham CR, Zannis VI. Biochemistry; 1997 Aug 26; 36(34):10571-80. PubMed ID: 9265639 [Abstract] [Full Text] [Related]
3. Structural variation manipulates the differential oxidative susceptibility and conformational stability of apolipoprotein E isoforms. Su KL, Wen TH, Chou CY, Chang GG, Liu GY, Hung HC. Proteins; 2007 Jul 01; 68(1):363-74. PubMed ID: 17410580 [Abstract] [Full Text] [Related]
4. Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism. Acharya P, Segall ML, Zaiou M, Morrow J, Weisgraber KH, Phillips MC, Lund-Katz S, Snow J. Biochim Biophys Acta; 2002 Sep 05; 1584(1):9-19. PubMed ID: 12213488 [Abstract] [Full Text] [Related]
5. The structure of human apolipoprotein E2, E3 and E4 in solution 1. Tertiary and quaternary structure. Barbier A, Clément-Collin V, Dergunov AD, Visvikis A, Siest G, Aggerbeck LP. Biophys Chem; 2006 Jan 20; 119(2):158-69. PubMed ID: 16139946 [Abstract] [Full Text] [Related]
6. Lipid binding ability of human apolipoprotein E N-terminal domain isoforms: correlation with protein stability? Weers PM, Narayanaswami V, Choy N, Luty R, Hicks L, Kay CM, Ryan RO. Biophys Chem; 2003 Jan 20; 100(1-3):481-92. PubMed ID: 12646385 [Abstract] [Full Text] [Related]
7. Single-step purification of two functional human apolipoprotein E variants hyperexpressed in Escherichia coli. Pillot T, Barbier A, Visvikis A, Lozac'h K, Rosseneu M, Vandekerckhove J, Siest G. Protein Expr Purif; 1996 Jun 20; 7(4):407-14. PubMed ID: 8776760 [Abstract] [Full Text] [Related]
8. Replacement of helix 1' enhances the lipid binding activity of apoE3 N-terminal domain. Redmond KA, Murphy C, Narayanaswami V, Kiss RS, Hauser P, Guigard E, Kay CM, Ryan RO. FEBS J; 2006 Feb 20; 273(3):558-67. PubMed ID: 16420479 [Abstract] [Full Text] [Related]
9. Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution. Chou CY, Lin YL, Huang YC, Sheu SY, Lin TH, Tsay HJ, Chang GG, Shiao MS. Biophys J; 2005 Jan 20; 88(1):455-66. PubMed ID: 15475580 [Abstract] [Full Text] [Related]
10. Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease. Morrow JA, Hatters DM, Lu B, Hochtl P, Oberg KA, Rupp B, Weisgraber KH. J Biol Chem; 2002 Dec 27; 277(52):50380-5. PubMed ID: 12393895 [Abstract] [Full Text] [Related]
11. Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils. Hatters DM, Zhong N, Rutenber E, Weisgraber KH. J Mol Biol; 2006 Sep 01; 361(5):932-44. PubMed ID: 16890957 [Abstract] [Full Text] [Related]
12. Isoform-specific interactions of human apolipoprotein E to an intermediate conformation of human Alzheimer amyloid-beta peptide. Stratman NC, Castle CK, Taylor BM, Epps DE, Melchior GW, Carter DB. Chem Phys Lipids; 2005 Oct 01; 137(1-2):52-61. PubMed ID: 16140289 [Abstract] [Full Text] [Related]
13. Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. Morrow JA, Segall ML, Lund-Katz S, Phillips MC, Knapp M, Rupp B, Weisgraber KH. Biochemistry; 2000 Sep 26; 39(38):11657-66. PubMed ID: 10995233 [Abstract] [Full Text] [Related]
14. Bacterial overexpression, isotope enrichment, and NMR analysis of the N-terminal domain of human apolipoprotein E. Fisher CA, Wang J, Francis GA, Sykes BD, Kay CM, Ryan RO. Biochem Cell Biol; 1997 Sep 26; 75(1):45-53. PubMed ID: 9192073 [Abstract] [Full Text] [Related]
15. Influence of tertiary structure domain properties on the functionality of apolipoprotein A-I. Tanaka M, Koyama M, Dhanasekaran P, Nguyen D, Nickel M, Lund-Katz S, Saito H, Phillips MC. Biochemistry; 2008 Feb 19; 47(7):2172-80. PubMed ID: 18205410 [Abstract] [Full Text] [Related]
16. Conformational stability of factor VIIa: biophysical studies of thermal and guanidine hydrochloride-induced denaturation. Freskgârd PO, Petersen LC, Gabriel DA, Li X, Persson E. Biochemistry; 1998 May 19; 37(20):7203-12. PubMed ID: 9585532 [Abstract] [Full Text] [Related]
17. Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice. Sheng H, Laskowitz DT, Bennett E, Schmechel DE, Bart RD, Saunders AM, Pearlstein RD, Roses AD, Warner DS. J Cereb Blood Flow Metab; 1998 Apr 19; 18(4):361-6. PubMed ID: 9538900 [Abstract] [Full Text] [Related]
18. Composition and structural and functional properties of discoidal and spherical phospholipid-apoE3 complexes. De Pauw M, Vanloo B, Dergunov AD, Devreese AM, Baert J, Brasseur R, Rosseneu M. Biochemistry (Mosc); 1997 Mar 19; 62(3):251-63. PubMed ID: 9275298 [Abstract] [Full Text] [Related]
19. Apolipoprotein E expression and purification. Newhouse Y, Weisgraber KH. Methods Mol Biol; 2011 Mar 19; 670():127-40. PubMed ID: 20967588 [Abstract] [Full Text] [Related]
20. Comparative in vivo metabolism of apolipoproteins E2 and E4 in heterozygous apoE2/4 subjects. Ikewaki K, Zech LA, Brewer HB, Rader DJ. J Lab Clin Med; 2002 Nov 19; 140(5):369-74. PubMed ID: 12434139 [Abstract] [Full Text] [Related] Page: [Next] [New Search]